GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,000 | 0.0% | 16,140 | +45.7% | 0.00% | – |
| Q2 2023 | $61,000 | +52.5% | 11,076 | +22.0% | 0.00% | – |
| Q1 2023 | $40,000 | -20.0% | 9,079 | -29.5% | 0.00% | – |
| Q4 2022 | $50,000 | +35.1% | 12,875 | +85.6% | 0.00% | – |
| Q3 2022 | $37,000 | -14.0% | 6,936 | +4.9% | 0.00% | – |
| Q2 2022 | $43,000 | -35.8% | 6,613 | -26.9% | 0.00% | – |
| Q1 2022 | $67,000 | -40.7% | 9,043 | -44.0% | 0.00% | – |
| Q4 2021 | $113,000 | -21.0% | 16,162 | +183.6% | 0.00% | – |
| Q3 2021 | $143,000 | +21.2% | 5,698 | +30.2% | 0.00% | – |
| Q2 2021 | $118,000 | -33.7% | 4,376 | -29.9% | 0.00% | – |
| Q1 2021 | $178,000 | +196.7% | 6,242 | +192.9% | 0.00% | – |
| Q4 2020 | $60,000 | +400.0% | 2,131 | +432.8% | 0.00% | – |
| Q3 2020 | $12,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $35,601,781 | 4.82% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,396,909 | 0.86% |
| Artal Group S.A. | 2,814,191 | $12,101 | 0.72% |
| PFM Health Sciences, LP | 2,648,297 | $11,387,677 | 0.50% |
| SVB FINANCIAL GROUP | 40,401 | $173,724 | 0.33% |
| SECTORAL ASSET MANAGEMENT INC | 385,070 | $1,655,801 | 0.32% |
| Yiheng Capital Management, L.P. | 1,601,766 | $6,887,594 | 0.27% |
| EcoR1 Capital, LLC | 1,956,579 | $8,413,290 | 0.27% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,194,522 | 0.23% |
| Bellevue Group AG | 3,620,280 | $15,567,204 | 0.23% |